<DOC>
	<DOCNO>NCT02277483</DOCNO>
	<brief_summary>Evaluation efficacy safety SLIT LAIS® Mites Sublingual tablet compare standard drug treatment patient age 60 year suffer house dust mite ( HDM ) induce allergic rhino-conjunctivitis with/without asthma .</brief_summary>
	<brief_title>Efficacy Safety LAIS® Mites Sublingual Tablets</brief_title>
	<detailed_description>The Total combine score ( TCS ) , take account rhinoconjunctivitis total symptom score ( RTSS ) total rescue medication score ( RTMS ) , maximum expect mite exposition period ( V4-V5 ) For RTSS RTMS , daily value determine patient diary card collect observation period 30 day . Then , mean daily score period calculate parameter .</detailed_description>
	<criteria>1 . Female male patient age 60 year history least two year house dust mite ( HDM ) induce allergic rhinitis and/or allergic rhinoconjunctivitis without mild moderate control asthma upon exposure house dust mite [ From Global Strategy Asthma Management Prevention , Global Initiative Asthma ( GINA ) 2007 . 2 . Clinically relevant sensitization mite . 3 . Positive clinical history allergy due house dust mite ( HDM ) , proven The majority perennial clinical symptom appear mostly relate indoor mite allergens Specific Immunoglobulin E reactivity mite allergen ( ImmunoCAP &gt; 0.35 Ku/L ) Positive skin prick test ( wheal diameter &gt; 3mm , negative control &lt; 2mm ) 4 . Retrospective Total Symptom Score ( RRTSS ) refer previous winter season great equal 8 5 . Compliance ability patient complete diary card selfevaluation symptom antisymptomatic medication 6 . Signed date patient 's Informed Consent 1 . Simultaneous participation clinical trial 2 . Previous immunotherapy mite allergens cross react allergen within last 5 year 3 . Ongoing immunotherapy allergen 4 . Patients relationship dependency sponsor and/or investigator 5 . Other reason contraindicate inclusion trial accord investigator 's estimation ( e.g . poor compliance , inability patient understand study document instruction ) 6 . Predominant seasonal allergic rhinitis 7 . Patients clinically relevant sensitization seasonal aeroallergens occur study period may include . Also patient clinically relevant sensitization perennial allergen like animal dander may include 8 . Uncontrolled asthma 9 . Chronic asthma emphysema , particularly forced expiratory volume &lt; 70 % predict value /or &lt; 70 % individual optimum value 10 . Infections oral cavity severe symptom 11 . Patients Galactoseintolerance , Lactasedeficiency , GlucoseGalactosemalabsorption 12 . Active tuberculosis 13 . Generally inflammatory well severe acute chronic inflammatory diseases 14 . Irreversible secondary disorder target organ ( e.g . emphysema , bronchiectasis ) 15 . Immune deficiency ( example induce immunosuppressive drug ) 16 . Physician diagnose disease liver , spleen , nervous system , thyroidal gland well rheumatic disease , base autoimmune mechanism , 17 . Malignancy 18 . Alcohol abuse well drug / medication abuse 19 . Patients treat contraindicated drug 20 . Contraindication adrenalin ( example , acute chronic symptomatic coronary heart disease , severe hypertension , hyperthyroidism ) 21 . Completed ongoing longterm treatment tranquilizer psycho active drug 22 . Completed ongoing treatment antiSpecific Immunoglobulin Eantibody 23 . Uncontrolled asthma accord GINA guideline criterion</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>